Latest Period
Q1 2026
Security Snapshot
Ascendis Pharma A/S - American Depositary Shares (ASND) Institutional Ownership
CUSIP: 04351P101
13F Institutional Holders and Ownership History from Q1 2015 to Q1 2026
Institutions Reporting
259
Shares (Excl. Options)
53,737,475
Price
$228.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / American Depositary Shares
- Symbol
- ASND on Nasdaq
- Shares outstanding
- 61,990,867
- Price per share
- $244.48
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 53,737,475
- Total reported value
- $12,280,178,069
- % of total 13F portfolios
- 0.01%
- Share change
- -10,370,267
- Value change
- -$2,216,725,568
- Number of holders
- 259
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ASND - Ascendis Pharma A/S - American Depositary Shares is tracked under CUSIP 04351P101.
- 259 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 304 to 259 between Q4 2025 and Q1 2026.
- Reported value moved from $13,781,007,160 to $12,280,178,069.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 259 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - American Depositary Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 04351P101:
Significant Owners of Ascendis Pharma A/S - American Depositary Shares (ASND) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10% | +114% | $1,617,120,732 | +$954,097,949 | 6,506,219 | +144% | T. Rowe Price Investment Management, Inc. | 30 Apr 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8.5% | -7.8% | $1,115,183,925 | -$73,663,872 | 5,185,696 | -6.2% | Westfield Capital Management Company, L.P. | 31 Dec 2025 |
| FMR LLC | 6.6% | -18% | $957,439,699 | -$197,557,979 | 3,852,101 | -17% | FMR LLC | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC | 6% | -22% | $924,469,795 | -$150,026,520 | 3,719,452 | -14% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| Artisan Partners Limited Partnership | 5.2% | $687,887,717 | 3,225,885 | Artisan Partners Asset Management Inc. | 31 Dec 2025 | |||
| Capital International Investors | 5.6% | $548,747,120 | 3,109,225 | Capital International Investors | 30 Jun 2025 |
As of 31 Mar 2026, 259 institutional investors reported holding 53,737,475 shares of Ascendis Pharma A/S - American Depositary Shares (ASND). This represents 87% of the company’s total 61,990,867 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Ascendis Pharma A/S - American Depositary Shares (ASND) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 17% | 10,281,496 | 0% | 25% | $2,351,686,580 |
| Avoro Capital Advisors LLC | 8.2% | 5,062,500 | -0.95% | 11% | $1,157,945,625 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7.8% | 4,813,440 | -7.2% | 4.6% | $1,100,978,089 |
| FMR LLC | 6.3% | 3,876,601 | -6.7% | 0.05% | $886,694,943 |
| Artisan Partners Limited Partnership | 5.2% | 3,230,188 | +0.13% | 1.2% | $738,840,836 |
| FRANKLIN RESOURCES INC | 3.3% | 2,051,948 | +7.4% | 0.11% | $469,341,976 |
| Capital International Investors | 3.2% | 1,958,843 | -36% | 0.11% | $448,046,159 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3% | 1,860,669 | -1.4% | 0.15% | $425,574,778 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8% | 1,757,633 | -0.29% | 0.08% | $402,023,397 |
| PERCEPTIVE ADVISORS LLC | 2.5% | 1,531,421 | +42% | 6.9% | $350,281,925 |
| AMERICAN CENTURY COMPANIES INC | 2.3% | 1,397,119 | -3.2% | 0.16% | $319,564,431 |
| Capital World Investors | 1.5% | 900,517 | 0.03% | $205,975,253 | |
| PRINCIPAL FINANCIAL GROUP INC | 1.4% | 896,397 | -13% | 0.11% | $205,032,887 |
| BlackRock, Inc. | 1.1% | 661,054 | +5.2% | 0% | $151,202,889 |
| Polar Capital Holdings Plc | 1.1% | 651,712 | +76% | 0.65% | $149,066,086 |
| MORGAN STANLEY | 0.98% | 606,348 | -1.9% | 0.01% | $138,690,183 |
| GOLDMAN SACHS GROUP INC | 0.91% | 566,192 | -5.1% | 0.02% | $129,505,096 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 0.9% | 556,427 | +12% | 0.22% | $127,272,000 |
| JPMORGAN CHASE & CO | 0.87% | 539,434 | +6.3% | 0.01% | $117,785,480 |
| AMERIPRISE FINANCIAL INC | 0.77% | 476,466 | -13% | 0.03% | $108,982,068 |
| FIL Ltd | 0.72% | 447,421 | -6.5% | 0.08% | $102,338,605 |
| Vestal Point Capital, LP | 0.6% | 375,000 | +114% | 2.4% | $85,773,750 |
| Invesco Ltd. | 0.58% | 362,109 | -38% | 0.01% | $82,825,192 |
| SEI INVESTMENTS CO | 0.57% | 351,146 | +25% | 0.07% | $80,317,658 |
| BNP PARIBAS FINANCIAL MARKETS | 0.5% | 309,173 | 0% | 0.05% | $70,717,140 |
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 53,737,475 | $12,280,178,069 | -$2,216,725,568 | $228.73 | 259 |
| 2025 Q4 | 64,677,198 | $13,781,007,160 | +$36,599,194 | $213.24 | 304 |
| 2025 Q3 | 63,798,487 | $12,683,838,954 | +$232,138,786 | $198.81 | 279 |
| 2025 Q2 | 62,895,390 | $10,855,906,781 | -$373,773,069 | $172.60 | 245 |
| 2025 Q1 | 65,180,066 | $10,147,446,038 | +$223,136,493 | $155.86 | 241 |
| 2024 Q4 | 63,751,521 | $8,776,308,689 | +$115,863,512 | $137.67 | 212 |
| 2024 Q3 | 62,595,716 | $9,312,956,409 | +$237,478,312 | $149.31 | 218 |
| 2024 Q2 | 60,687,245 | $8,276,478,215 | -$25,623,552 | $136.38 | 202 |
| 2024 Q1 | 60,791,422 | $9,189,438,728 | +$198,420,492 | $151.17 | 188 |
| 2023 Q4 | 60,262,338 | $7,590,188,894 | -$95,295,592 | $125.95 | 183 |
| 2023 Q3 | 60,279,508 | $5,644,577,484 | -$61,738,785 | $93.64 | 157 |
| 2023 Q2 | 61,039,136 | $5,447,708,812 | -$42,606,636 | $89.25 | 156 |
| 2023 Q1 | 60,982,797 | $6,535,152,679 | -$603,913,240 | $107.22 | 160 |
| 2022 Q4 | 65,956,055 | $8,054,269,679 | -$66,421,048 | $122.13 | 183 |
| 2022 Q3 | 66,716,414 | $6,891,080,476 | +$149,538,106 | $103.26 | 177 |
| 2022 Q2 | 63,211,628 | $5,875,622,934 | +$99,259,708 | $92.96 | 162 |
| 2022 Q1 | 61,928,932 | $7,267,064,424 | +$416,027,513 | $117.36 | 169 |
| 2021 Q4 | 58,376,386 | $7,851,336,290 | -$60,447,865 | $134.53 | 168 |
| 2021 Q3 | 58,008,737 | $9,244,880,979 | +$506,030,857 | $159.39 | 162 |
| 2021 Q2 | 55,049,436 | $7,239,726,130 | +$277,622,452 | $131.55 | 167 |
| 2021 Q1 | 52,687,197 | $6,790,538,552 | -$259,999,867 | $128.88 | 172 |
| 2020 Q4 | 54,357,110 | $9,065,494,890 | +$123,538,090 | $166.78 | 173 |
| 2020 Q3 | 53,548,292 | $8,263,618,101 | +$776,855,285 | $154.32 | 150 |
| 2020 Q2 | 48,248,343 | $7,132,005,530 | +$39,025,561 | $147.90 | 149 |
| 2020 Q1 | 47,871,754 | $5,391,239,456 | +$191,350,357 | $112.61 | 143 |
| 2019 Q4 | 46,149,738 | $6,420,287,137 | -$13,680,500 | $139.12 | 139 |
| 2019 Q3 | 46,122,563 | $4,442,511,426 | -$194,325,083 | $96.32 | 127 |
| 2019 Q2 | 47,663,417 | $5,487,484,115 | +$237,283,765 | $115.15 | 132 |
| 2019 Q1 | 45,989,019 | $5,412,737,939 | +$716,635,309 | $117.70 | 137 |
| 2018 Q4 | 40,100,469 | $2,509,199,237 | -$10,826,186 | $62.65 | 102 |
| 2018 Q3 | 40,188,306 | $2,847,498,166 | +$44,455,437 | $70.86 | 94 |
| 2018 Q2 | 39,572,750 | $2,632,379,192 | +$96,237,781 | $66.52 | 100 |
| 2018 Q1 | 38,126,373 | $2,493,396,132 | +$345,130,853 | $65.40 | 89 |
| 2017 Q4 | 30,513,340 | $1,222,363,447 | +$50,139,269 | $40.06 | 64 |
| 2017 Q3 | 28,774,674 | $1,042,816,000 | +$204,057,698 | $36.25 | 59 |
| 2017 Q2 | 23,269,447 | $646,000,000 | +$80,276,736 | $27.76 | 34 |
| 2017 Q1 | 20,898,775 | $585,169,000 | +$9,050,400 | $28.00 | 34 |
| 2016 Q4 | 20,561,240 | $416,160,000 | +$130,784,664 | $20.24 | 31 |
| 2016 Q3 | 13,995,656 | $281,311,000 | +$4,791,129 | $20.10 | 22 |
| 2016 Q2 | 13,876,594 | $184,147,000 | +$10,182,326 | $13.27 | 23 |
| 2016 Q1 | 12,036,579 | $223,242,000 | +$9,842,726 | $18.55 | 25 |
| 2015 Q4 | 10,090,990 | $184,865,000 | +$7,675,460 | $18.32 | 24 |
| 2015 Q3 | 8,925,979 | $157,986,000 | -$15,929 | $17.70 | 24 |
| 2015 Q2 | 8,953,630 | $157,820,000 | +$7,731,541 | $17.68 | 32 |
| 2015 Q1 | 8,477,992 | $145,818,000 | +$145,818,000 | $17.35 | 35 |